Publication

Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study

Janssen, P. G. H., Gorter, K. J., Stolk, R. P., Akarsubasi, M. & Rutten, G. E. H. M., 16-Dec-2008, In : BMC Family Practice. 9, 7 p., 67.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Janssen, P. G. H., Gorter, K. J., Stolk, R. P., Akarsubasi, M., & Rutten, G. E. H. M. (2008). Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study. BMC Family Practice, 9, [67]. https://doi.org/10.1186/1471-2296-9-67

Author

Janssen, Paul G. H. ; Gorter, Kees J. ; Stolk, Ronald P. ; Akarsubasi, Mehmet ; Rutten, Guy E. H. M. / Three years follow-up of screen-detected diabetic and non-diabetic subjects : who is better off? The ADDITION Netherlands study. In: BMC Family Practice. 2008 ; Vol. 9.

Harvard

Janssen, PGH, Gorter, KJ, Stolk, RP, Akarsubasi, M & Rutten, GEHM 2008, 'Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study', BMC Family Practice, vol. 9, 67. https://doi.org/10.1186/1471-2296-9-67

Standard

Three years follow-up of screen-detected diabetic and non-diabetic subjects : who is better off? The ADDITION Netherlands study. / Janssen, Paul G. H.; Gorter, Kees J.; Stolk, Ronald P.; Akarsubasi, Mehmet; Rutten, Guy E. H. M.

In: BMC Family Practice, Vol. 9, 67, 16.12.2008.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Janssen PGH, Gorter KJ, Stolk RP, Akarsubasi M, Rutten GEHM. Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study. BMC Family Practice. 2008 Dec 16;9. 67. https://doi.org/10.1186/1471-2296-9-67


BibTeX

@article{1e9df4acbd684ff9975093c06e9f40b3,
title = "Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study",
abstract = "Background: People with non-diabetic hyperglycaemia might be at risk of lacking adequate control for cardiovascular risk factors. Our aim was to determine the extent of health care utilization and provision in primary care and to evaluate the risk of cardiovascular disease in persons with an elevated risk score in a stepwise diabetes screening programme.Methods: A total of 56,978 non-diabetic patients, aged 50-70 years, from 79 practices in the Netherlands were invited to participate in a screening programme starting with a questionnaire. Those with an elevated score, underwent further glucose testing. Screened participants with type 2 diabetes (n = 64), impaired glucose tolerance (IGT) (n = 62), impaired fasting glucose (IFG) (n = 86), and normal glucose tolerance (NGT) (n = 142) were compared after three years regarding use of medication, care provider encounters and occurrence of CVD.Results: In all glucose regulation categories cardiovascular medication was prescribed more frequently during follow-up with the strongest increase in diabetic patients. Number of practice visits was higher in diabetic patients compared to those in the other categories. Glucose, lipids, and blood pressure were measured most frequently in diabetic patients. Numbers of cardiovascular events in participants with NGT, IFG, IGT and diabetes were 16.7, 32.6, 17.3 and 15.7 per 1,000 person-years (non significant), respectively.Conclusion: After three years of follow-up, screened non-diabetic participants with an elevated risk score had cardiovascular event rates comparable with diabetic patients. Screened non-diabetic persons are at risk of lacking optimal control for cardiovascular risk factors while screen-detected diabetic patients were controlled adequately.",
keywords = "IMPAIRED GLUCOSE-TOLERANCE, FASTING GLUCOSE, RISK-FACTORS, LIFE-STYLE, POPULATION, INTERVENTION, COMPLICATIONS, DEFINITION, PREVENTION, MORTALITY",
author = "Janssen, {Paul G. H.} and Gorter, {Kees J.} and Stolk, {Ronald P.} and Mehmet Akarsubasi and Rutten, {Guy E. H. M.}",
year = "2008",
month = "12",
day = "16",
doi = "10.1186/1471-2296-9-67",
language = "English",
volume = "9",
journal = "BMC Family Practice",
issn = "1471-2296",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Three years follow-up of screen-detected diabetic and non-diabetic subjects

T2 - who is better off? The ADDITION Netherlands study

AU - Janssen, Paul G. H.

AU - Gorter, Kees J.

AU - Stolk, Ronald P.

AU - Akarsubasi, Mehmet

AU - Rutten, Guy E. H. M.

PY - 2008/12/16

Y1 - 2008/12/16

N2 - Background: People with non-diabetic hyperglycaemia might be at risk of lacking adequate control for cardiovascular risk factors. Our aim was to determine the extent of health care utilization and provision in primary care and to evaluate the risk of cardiovascular disease in persons with an elevated risk score in a stepwise diabetes screening programme.Methods: A total of 56,978 non-diabetic patients, aged 50-70 years, from 79 practices in the Netherlands were invited to participate in a screening programme starting with a questionnaire. Those with an elevated score, underwent further glucose testing. Screened participants with type 2 diabetes (n = 64), impaired glucose tolerance (IGT) (n = 62), impaired fasting glucose (IFG) (n = 86), and normal glucose tolerance (NGT) (n = 142) were compared after three years regarding use of medication, care provider encounters and occurrence of CVD.Results: In all glucose regulation categories cardiovascular medication was prescribed more frequently during follow-up with the strongest increase in diabetic patients. Number of practice visits was higher in diabetic patients compared to those in the other categories. Glucose, lipids, and blood pressure were measured most frequently in diabetic patients. Numbers of cardiovascular events in participants with NGT, IFG, IGT and diabetes were 16.7, 32.6, 17.3 and 15.7 per 1,000 person-years (non significant), respectively.Conclusion: After three years of follow-up, screened non-diabetic participants with an elevated risk score had cardiovascular event rates comparable with diabetic patients. Screened non-diabetic persons are at risk of lacking optimal control for cardiovascular risk factors while screen-detected diabetic patients were controlled adequately.

AB - Background: People with non-diabetic hyperglycaemia might be at risk of lacking adequate control for cardiovascular risk factors. Our aim was to determine the extent of health care utilization and provision in primary care and to evaluate the risk of cardiovascular disease in persons with an elevated risk score in a stepwise diabetes screening programme.Methods: A total of 56,978 non-diabetic patients, aged 50-70 years, from 79 practices in the Netherlands were invited to participate in a screening programme starting with a questionnaire. Those with an elevated score, underwent further glucose testing. Screened participants with type 2 diabetes (n = 64), impaired glucose tolerance (IGT) (n = 62), impaired fasting glucose (IFG) (n = 86), and normal glucose tolerance (NGT) (n = 142) were compared after three years regarding use of medication, care provider encounters and occurrence of CVD.Results: In all glucose regulation categories cardiovascular medication was prescribed more frequently during follow-up with the strongest increase in diabetic patients. Number of practice visits was higher in diabetic patients compared to those in the other categories. Glucose, lipids, and blood pressure were measured most frequently in diabetic patients. Numbers of cardiovascular events in participants with NGT, IFG, IGT and diabetes were 16.7, 32.6, 17.3 and 15.7 per 1,000 person-years (non significant), respectively.Conclusion: After three years of follow-up, screened non-diabetic participants with an elevated risk score had cardiovascular event rates comparable with diabetic patients. Screened non-diabetic persons are at risk of lacking optimal control for cardiovascular risk factors while screen-detected diabetic patients were controlled adequately.

KW - IMPAIRED GLUCOSE-TOLERANCE

KW - FASTING GLUCOSE

KW - RISK-FACTORS

KW - LIFE-STYLE

KW - POPULATION

KW - INTERVENTION

KW - COMPLICATIONS

KW - DEFINITION

KW - PREVENTION

KW - MORTALITY

U2 - 10.1186/1471-2296-9-67

DO - 10.1186/1471-2296-9-67

M3 - Article

VL - 9

JO - BMC Family Practice

JF - BMC Family Practice

SN - 1471-2296

M1 - 67

ER -

ID: 4843971